Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Manuel Roehrich"'
Autor:
Andreas L. Buck, Uwe Haberkorn, Fabian Staudinger, Frederik L. Giesel, Clemens Kratochwil, David Sennung, Joel Schlittenhardt, Jens Cardinale, Thomas Lindner, Wolfgang P. Fendler, Sebastian Serfling, Jeremie Calais, Katharina Dendl, Juergen Debus, Stefan A. Koerber, Mike Sathekge, Lukas Kessler, Manuel Roehrich, Matthias Eiber
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 48:4377-4385
Purpose FAPI ligands (fibroblast activation protein inhibitor), a novel class of radiotracers for PET/CT imaging, demonstrated in previous studies rapid and high tumor uptake. The purpose of this study is the head-to-head intra-individual comparison
Autor:
Frederik L, Giesel, Clemens, Kratochwil, Joel, Schlittenhardt, Katharina, Dendl, Matthias, Eiber, Fabian, Staudinger, Lukas, Kessler, Wolfgang P, Fendler, Thomas, Lindner, Stefan A, Koerber, Jens, Cardinale, David, Sennung, Manuel, Roehrich, Juergen, Debus, Mike, Sathekge, Uwe, Haberkorn, Jeremie, Calais, Sebastian, Serfling, Andreas L, Buck
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Purpose FAPI ligands (fibroblast activation protein inhibitor), a novel class of radiotracers for PET/CT imaging, demonstrated in previous studies rapid and high tumor uptake. The purpose of this study is the head-to-head intra-individual comparison
Autor:
Line Hoeltgen, Manuel Roehrich, Nils H. Nicolay, Peter E. Huber, Kai Hauser, Falk Roeder, Sebastian Bickelhaupt, Michael Lahn, J�rgen Jenne, Paul Flechsig, Monika Dadrich, Alexandra Tietz, Ramon Lopez, Ute Wirkner
Publikováno v:
Oncoimmunology
Background: Radiotherapy (RT) is a mainstay for the treatment of lung cancer, but the effective dose is often limited by the development of radiation-induced pneumonitis and pulmonary fibrosis. Transforming growth factor β (TGFβ) and platelet-deriv
Autor:
Juergen Debus, Juergen Jenne, Kenneth E. Lipson, Mengxian Zhang, David Capper, Thuy Trinh, Peter E. Huber, Carmen Timke, Ute Wirkner, Manuel Roehrich
Publikováno v:
Molecular Cancer Therapeutics. 10:B206-B206
Objective: Despite progress in understanding molecular changes in glioblastoma multiforme (GBM), it remains a cancer with poor prognosis in need of better therapy. Pathological features of GBM are explosive growth, angiogenesis and its unique diffuse